Aspira Women’s Health

Aspira Women’s Health 是一家在股票代码 AWH (US) 下上市的公司。

查看带有其 14 名主要高管的组织结构图

Aspira Women’s Health 搜索最多的简介

• Sandra Milligan, Interim Chief Executive Officer
• Celeste Fralick, Director
• Stefanie Cavanaugh, Independent Director

高管在Aspira Women’s Health变化

• Nicole Sandford, Director, President and Chief Executive Officer, 已经离开公司  (新闻发布的2024十二月16号).
• Sandra Milligan 曾任 President, 现升职为 Interim Chief Executive Officer  (新闻发布的2024十二月16号).
• John Ragard已作为Director加入公司  (新闻发布的2024七月30号).

更多的变化在％s

创建提醒
跟踪 Aspira Women’s Health 的高管变动

Aspira Women’s Health 拥有 1,005 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。

Popular M&A news in 医疗设备

• Precision Neuroscience 刚刚宣布为 102 筹款数百万美元。 (公布2024十二月18号).
• electroCore 已收购 NeuroMetrix (公布2024十二月18号).
• Anteris Technologies 刚刚宣布为 89 筹款数百万美元。 (公布2024十二月16号).

医疗设备 行业的其他推荐联系人

• Medical Microinstruments 企业 Andrew Elbardissi - Director
• Thermo Fisher Scientific 企业 Marc Casper - Chairman of the Board, President and Chief Executive Officer
• Illumina 企业 Frances Arnold - Director

了解更多有关医疗设备行业的信息 >

Aspira Women’s Health 的最新新闻稿

• Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® – Aspira Women's Health
• Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 – Aspira Women's Health
• Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health – Aspira Women's Health
• Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 – Aspira Women's Health
• Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® – Aspira Women's Health
• Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass – Aspira Women's Health
• Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference – Aspira Women's Health
• View more press releases Close

关于 Aspira Women’s Health 的社交媒体

• Aspira Women’s Health 在 维基百科、谷歌新闻 和 雅虎财经
• Aspira Women’s Health 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Celeste Fralick

致电Aspira Women’s Health，电话：+1 512...

查看组织结构图

Register to receive your alert

报告错误